|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,514.00 GBX | -0.57% |
|
-1.31% | +29.10% |
| 12:03pm | Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in small trial | RE |
| 05:05pm | Banks support FTSE 100 ahead of Fed decision | RE |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | GBX 199.37 | +10.17% | 19 | ||||||
| US$1,063.89 | +8.31% | 27 | ||||||
| US$203.42 | +1.73% | 24 | ||||||
| US$243.55 | +9.22% | 29 | ||||||
| CHF 318.45 | +1% | 18 | ||||||
| CHF 133.55 | +0.78% | 19 | ||||||
| US$106.62 | +10.04% | 26 | ||||||
| DKK 390.79 | +30.61% | 20 | ||||||
| US$324.25 | +3.32% | 27 | ||||||
| US$130.76 | +9.55% | 26 | ||||||
| US$29.04 | +14.64% | 24 | ||||||
| €106.13 | +27.52% | 21 | ||||||
| US$487.28 | +11.5% | 25 | ||||||
| US$53.41 | +5.45% | 22 | ||||||
| GBX 18.47 | +3.59% | 18 | ||||||
| JP¥8,553.57 | +4.48% | 14 | ||||||
| CN¥81.04 | +28.47% | 18 | ||||||
| US$492.17 | +18.53% | 24 | ||||||
| JP¥4,946.14 | +10.04% | 14 | ||||||
| Average | 941.15 | +11.00% | 22 | ||||||
| Weighted average by Cap. | 612.19 | +8.79% | 23 |
- Stock Market
- Equities
- AZN Stock
- Sector AstraZeneca PLC
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition